Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the advancement of its matrix metalloproteinase-9 (MMP9) ...
The U.S. Army created a new AI and machine learning officer career field, launching initial selections through VTIP in 2026.
Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...
InterVenn Biosciences, a precision diagnostics company advancing liquid biopsy with glycoproteomics, and Aranscia, a global provider of award-winning clinical workflow and diagnostic technology ...
JESY Nelson fought back tears during an emotional TV interview today after her twin daughters were diagnosed with a ...
This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...
Variant Bio, a genomics-driven AI drug discovery company, today announced a multi-year research collaboration and license agreement with Boehringer Ingelheim. The partnership will focus on the ...
Fred Hutch researchers launch free online tool to assess colorectal cancer risk Researchers led by Ulrike “Riki” Peters, PhD, MPH, holder of the 40th Anniversary Endowed Chair, and Li Hsu, PhD, ...
PlusAI, a leader in AI software for autonomous trucks, today announced the appointment of two new Board members, David C. Peterschmidt and Harry J. Harczak, Jr., seasoned leaders with decades of ...
Foundation funds five new research projects, bringing 2025 total to $5.2 millionNEW YORK, Jan. 6, 2026 /PRNewswire/ -- The ...
Gautam Menon, professor at Ashoka University, and his team modeled a potential H5N1 spillover in a poultry district. Their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback